MET inhibitor Compound 1

• Description:

  A novel potent, selective orally bioavailable MET tyrosine kinase inhibitor with IC50 of <1 nM and 12 nM for unphosphorylated and phosphorylaed MET, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  449.426

• Molecular Formula:

  C21H17F2N9O

• Notes:

  Research use only, not for human use.

• Receptor:

  C-Met/HGFR

• CAS Number:

  1208248-23-0